Skip to main content
Skip to main content
RHCGF logo

Ryman Healthcare Limited (RHCGF) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$1.11 +$0.1216 (+12.28%) |CouncilSplit View · 48 · C
MCap: $1.13B| Vol: 500| 52-wk range: $0.99 – $1.75

Market cap $1.13B is the value of all shares combined. Beta 0.22: the stock has moved about 78% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Ryman Healthcare Limited (RHCGF) trades at $1.11. Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. Market cap: $1.13B, Sector: Healthcare.

Price as of Sep 11, 2026 · Last analyzed: Mar 17, 2026
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company provides a range of retirement living and care options, including independent living, assisted living, and dementia care.

Analyst Coverage for RHCGF: RHCGF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RHCGF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the RHCGF film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.

Council Score · Weighted Average of 3 Disciplines
Split View 48/100 · C

RHCGF: the 2 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Englander-style lens (simulated)Izzy Englander
Unfavorable read
Klarman-style lens (simulated)Seth Klarman
Favorable read
Moon AI lens (model)
Unfavorable read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Ryman Healthcare Limited (RHCGF) Healthcare & Pipeline Overview

CEONaomi James
Employees7,700
HeadquartersChristchurch, NZ
IPO Year2013

Ryman Healthcare Limited, a New Zealand-based company, develops and operates integrated retirement villages and care facilities across New Zealand and Australia, offering a continuum of care from independent living to hospital-level services. The company distinguishes itself through its comprehensive village amenities and a focus on providing high-quality care for the elderly.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for RHCGF?

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Ryman Healthcare presents a mixed investment case. While the aging populations in New Zealand and Australia provide a strong demographic tailwind, the company's recent negative profit margin of -75.9% raises concerns about operational efficiency and profitability. The low beta of 0.22 suggests lower volatility compared to the overall market. Future growth hinges on successful expansion and the ability to improve cost management. Investors should closely monitor occupancy rates, development timelines, and the competitive landscape to assess Ryman's long-term potential. The absence of a dividend yield may deter income-focused investors.

Based on FMP financials and quantitative analysis

RHCGF Key Highlights

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Ryman Healthcare operates 45 retirement villages across New Zealand and Australia.

  • The company provides a continuum of care, including independent living, assisted living, and hospital-level care.
  • Ryman's villages offer a range of amenities, such as swimming pools, gyms, and movie theaters.
  • The company's profit margin is currently negative, at -75.9%.
  • Ryman Healthcare's beta is 0.22, indicating lower volatility than the market.

Who Are RHCGF's Competitors?

RHCGF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
ANSLY Ansell Limited $107.84 0.00% $3.79B
BUGDF Bumrungrad Hospital Public Company Limited $4.75 0.00% $3.78B
GLPGF Galapagos N.V. $26.24 0.00% $1.73B
JXFGF Jinxin Fertility Group Limited $0.29 0.00% $740M
MAHLY MediPal Holdings Corporation $18.30 0.00% $3.75B
USPH U.S. Physical Therapy, Inc. $78.52 +1.04% $1.19B 605-pillar
AMN AMN Healthcare Services, Inc. $33.47 +1.27% $1.30B 935-pillar
PNTG The Pennant Group, Inc. $39.55 +0.64% $1.38B 695-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are RHCGF's Key Strengths?

Integrated retirement village model.

  • Established brand reputation.
  • High-quality facilities and services.
  • Continuum of care.

What Are RHCGF's Weaknesses?

Negative profit margin.

  • Exposure to property market fluctuations.
  • High capital expenditure requirements.
  • Dependence on occupancy rates.

What Could Drive RHCGF Stock Higher?

RHCGF catalyst: Aging populations in New Zealand and Australia driving demand for retirement living and aged care services.

  • Government support for aged care sector through funding and subsidies.
  • Potential expansion into new geographic markets.
  • Development of new retirement villages and care facilities.
  • Increasing demand for specialized care services, such as dementia care.

What Are the Key Risks for RHCGF?

Financial-distress signal — its Altman Z-Score of 0.38 sits in the distress zone (elevated bankruptcy risk).

  • Negative return on equity (-4.2%) — the business is not currently generating profit on shareholder capital.
  • Negative profit margin impacting financial performance.
  • Fluctuations in property markets affecting asset values.
  • Regulatory changes impacting operations and compliance costs.
  • Staffing shortages and rising labor costs.
  • Competition from other retirement village operators.

What Are the Growth Opportunities for RHCGF?

  • Expansion into New Markets: Ryman Healthcare has the opportunity to expand its footprint by developing new retirement villages in underserved areas of New Zealand and Australia. The aging population in both countries creates a strong demand for retirement living options. Successful expansion requires careful site selection, efficient project management, and effective marketing to attract new residents. This strategy could increase revenue by 10-15% over the next 3-5 years.
  • Increased Focus on High-Acuity Care: Ryman Healthcare can capitalize on the growing demand for specialized care services, such as dementia care and hospital-level care. By expanding its care offerings and investing in skilled staff, the company can attract residents with more complex healthcare needs. This strategy could improve occupancy rates and increase revenue per resident by 5-10% annually.
  • Development of Premium Retirement Villages: Ryman Healthcare can differentiate itself by developing premium retirement villages that offer enhanced amenities, personalized services, and a luxurious living environment. These villages can attract affluent retirees who are willing to pay a premium for high-quality accommodation and care. This strategy could increase profit margins by 2-3 percentage points.
  • Leveraging Technology to Enhance Care: Ryman Healthcare can improve the efficiency and effectiveness of its care services by leveraging technology, such as telehealth, remote monitoring, and electronic health records. These technologies can enable the company to provide more personalized care, reduce costs, and improve resident outcomes. Investment in technology could reduce operational costs by 5% over the next 2 years.
  • Strategic Partnerships: Ryman Healthcare can form strategic partnerships with healthcare providers, universities, and research institutions to enhance its care services, develop innovative solutions, and attract skilled staff. These partnerships can provide access to specialized expertise, research findings, and a pipeline of qualified healthcare professionals. Partnerships could improve care quality and attract more residents.

What Are RHCGF's Competitive Advantages?

  • Integrated model offering a continuum of care.
  • Established brand reputation in New Zealand and Australia.
  • Portfolio of high-quality retirement villages and care facilities.
  • Strong relationships with residents and their families.

What Does RHCGF Do?

Founded in 1984 and headquartered in Christchurch, New Zealand, Ryman Healthcare Limited has grown to become a leading provider of retirement living and aged care services in New Zealand and Australia. The company's core business involves developing, owning, and operating integrated retirement villages that cater to the diverse needs of the elderly population. Ryman's villages offer a range of accommodation options, including independent townhouses and apartments, serviced apartments, and care centers providing rest home, hospital, dementia, and respite care. These villages are designed to foster a sense of community and provide residents with access to a wide array of amenities, such as all-weather bowling greens, indoor heated swimming pools, gyms, libraries, dining rooms, and movie theaters. As of May 20, 2022, Ryman Healthcare operated 45 retirement villages, encompassing 8,538 retirement village units and 4,239 care units. The company's commitment to providing comprehensive care and lifestyle options has established it as a prominent player in the retirement village sector.

What Products and Services Does RHCGF Offer?

  • Develop and operate integrated retirement villages.
  • Provide independent living apartments and townhouses.
  • Offer serviced apartments with assistance for daily living.
  • Operate care centers providing rest home and hospital-level care.
  • Provide dementia care services.
  • Offer respite and day care services.
  • Provide amenities such as swimming pools, gyms, and movie theaters.

How Does RHCGF Make Money?

  • Generate revenue from the sale of retirement village units.
  • Earn ongoing fees from residents for accommodation, care, and services.
  • Develop and manage retirement villages and care facilities.
  • Provide a continuum of care, from independent living to hospital-level care.

What Industry Does RHCGF Operate In?

The retirement village industry in New Zealand and Australia is experiencing growth, driven by aging populations and increasing demand for specialized care and accommodation options. Ryman Healthcare operates within this competitive landscape, alongside companies like Arvida Group (ANSLY), offering a range of services from independent living to full-time care. The industry is subject to regulatory oversight and faces challenges related to land availability, construction costs, and staffing shortages. Market trends include a growing preference for integrated retirement villages that provide a continuum of care and a focus on enhancing residents' quality of life.

Who Are RHCGF's Key Customers?

  • Elderly individuals seeking retirement living options.
  • Individuals requiring assisted living or specialized care services.
  • Families seeking care for their elderly relatives.
  • Residents of New Zealand and Australia.
Model self-rating on this text: 73% (not a measure of the evidence) Updated: Mar 17, 2026

Research confidence

Low 34/100

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • Scoring coverage unknown
  • Price is current
  • Latest filing 164 days ago
  • No analyst coverage
  • Reported in NZD, converted to USD

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 42
2026-08-26 42
2026-08-29 42
2026-09-01 42
2026-09-04 42
2026-09-07 42
2026-09-10 42

What changed?

The score has stayed at 42.

Over the same 18 days the stock moved -33.1%.

Company Profile

Ryman Healthcare Limited operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Christchurch, NZ. The company is led by CEO Naomi James. RHCGF has traded publicly since 2013.

ROE -4%

Key Financial Metrics

Return on equity for Ryman Healthcare Limited stands at -4.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -1.4%, showing how much profit it generates from its asset base. Its free cash flow yield is 12.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.55 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -7.8%, the inverse of the P/E and a quick read on earnings relative to price.

RHCGF Valuation & Market Position

With a $1.13B market cap, Ryman Healthcare Limited sits in the small-cap segment of the market.

Quarterly Financial Performance: Ryman Healthcare Limited

Revenue for Ryman Healthcare Limited came in at $240.6M during Q4 FY2026, a 7.2% improvement versus the preceding quarter. The company recorded a net loss of $74.1M, with diluted EPS of $-0.08. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this small-cap Healthcare company. Across the four most recent quarters, RHCGF averaged $-0.11 in diluted EPS.

F-Score 4/9

Financial Health

Ryman Healthcare Limited's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.38 places it in the distress zone, a signal of elevated financial risk.

3/4 beats

Earnings Track Record

Ryman Healthcare Limited has beaten Wall Street's EPS estimate in 3 of its last 4 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 16.0% above estimates on average.

RHCGF Financials

Fundamental Snapshot

Revenue Growth (FY)
+13.0%
Net Income Growth (FY)
+60.4%
EPS Growth (FY)
+72.1%
Free Cash Flow Growth (FY)
-9.2%
Return on Equity (TTM)
-4.2%
Current Ratio
0.6
EV/EBITDA (TTM)
75.0

Based on FMP financials and quantitative analysis · FY 2026

Bull Case vs Bear Case

Bull Case

  • Integrated retirement village model.
  • Established brand reputation.
  • High-quality facilities and services.
  • Continuum of care.

Bear Case

  • Negative profit margin.
  • Exposure to property market fluctuations.
  • High capital expenditure requirements.
  • Dependence on occupancy rates.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q4 FY2026 $241M -$74M -$0.08
Q2 FY2026 $225M -$26M -$0.03
Q4 FY2025 $216M -$309M -$0.44
Q2 FY2025 $212M $55M $0.08

Q4 FY2026 · filed 31 Mar 2026 · Financial Modeling Prep

Based on FMP financials and quantitative analysis · Converted to USD from NZD at today's rate

RHCGF Latest News

No recent news available for RHCGF.

RHCGF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for RHCGF.

Price Targets

Wall Street price target analysis for RHCGF.

RHCGF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for RHCGF; grades run from A+ (80-100) to F (below 30).

Leadership: Naomi James

CEO

Naomi James is the Chief Executive Officer of Ryman Healthcare Limited. Her professional background includes extensive experience in the healthcare and aged care sectors. She has held various leadership positions, demonstrating expertise in strategic planning, operational management, and stakeholder engagement. Her educational background likely includes a relevant degree in business administration, healthcare management, or a related field. She is responsible for overseeing the company's overall strategy, operations, and financial performance.

Track Record: Under Naomi James's leadership, Ryman Healthcare has focused on expanding its presence in both New Zealand and Australia. She has overseen the development of new retirement villages and the enhancement of existing facilities. Her strategic decisions have aimed to improve the quality of care, enhance resident satisfaction, and drive sustainable growth. She is focused on navigating the challenges and opportunities presented by the aging populations in both countries.

RHCGF OTC Market Information

The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet minimum listing requirements of major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risk due to the potential for less transparency and regulatory oversight compared to exchange-listed companies. The OTC Other tier includes companies that are defunct, in bankruptcy, or unwilling or unable to provide current information to the public.

  • OTC Tier: OTC Other
Liquidity: Liquidity in OTC markets, particularly for OTC Other stocks like RHCGF, can be limited. Trading volume may be low, resulting in wider bid-ask spreads and potential difficulty in buying or selling shares quickly at desired prices. Investors should be aware of the potential for price volatility and consider using limit orders to manage risk. Due to the lower trading volume, it may be difficult to establish or exit a position without significantly impacting the price.
OTC Risk Factors:
  • Limited financial disclosure.
  • Lower liquidity and wider bid-ask spreads.
  • Potential for price manipulation.
  • Higher risk of fraud or scams.
  • Limited regulatory oversight.
Due Diligence Checklist:
  • Verify the company's registration and legal status.
  • Review available financial statements and disclosures.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team's experience and track record.
  • Understand the risks associated with the company's industry and operations.
  • Consult with a financial advisor.
  • Check for any regulatory actions or legal disputes.
Legitimacy Signals:
  • Longevity of operations (founded in 1984).
  • Significant employee base (7700 employees).
  • Operation of 45 retirement villages.
  • Physical presence in New Zealand and Australia.
  • Focus on providing essential services (aged care).

RHCGF Healthcare Stock FAQ

Is RHCGF a good stock?

Stock Expert AI does not rate RHCGF buy, sell or hold. Ryman Healthcare Limited has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What revenue streams does Ryman Healthcare Limited have in healthcare?

Ryman Healthcare Limited generates revenue primarily through accommodation fees, care fees, and other services provided to residents in its retirement villages and care facilities. Accommodation fees are derived from the sale or lease of retirement village units. Care fees are charged for the provision of rest home, hospital, dementia, and respite care services.

What are the key factors to evaluate for RHCGF?

Evaluate RHCGF on fundamentals, analyst consensus, and risk factors. Ryman Healthcare presents a mixed investment case. The low beta of 0.22 suggests lower volatility compared to the overall market. Not financial advice.

How frequently does RHCGF data refresh on this page?

RHCGF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven RHCGF's recent stock price performance?

Ryman Healthcare Limited (RHCGF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Integrated retirement village model. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider RHCGF overvalued or undervalued right now?

Ryman Healthcare Limited (RHCGF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of RHCGF?

Yes, most major brokerages offer fractional shares of Ryman Healthcare Limited (RHCGF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track RHCGF's earnings and financial reports?

Ryman Healthcare Limited (RHCGF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for RHCGF earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data may be outdated.
  • OTC market investments are speculative.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover